Clinical Trial Update: Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing efficacy and safety of once-daily tacrolimus in liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Liver Transplant | Phase 4 | Status: UNKNOWN